|
1
|
Nandkar SJ and Sonwane BR: A study of
tumours and tumour like lesions in the eye and its Adnexa: Our
experience of 80 cases with review of literature. IP Int J Ocul
Oncol Oculoplasty. 6:1–9. 2020.
|
|
2
|
Wei L, Wang J and Yu W: The haematology
and eye disease. In: Integrative Ophthalmology. Springer,
Singapore, pp179-185, 2020.
|
|
3
|
Baradaran PC, Kozovska Z, Furdova A and
Smolkova B: Targeting epigenetic modifications in uveal melanoma.
Int J Mol Sci. 21(5314)2020.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Aughton K, Kalirai H and Coupland SE:
MicroRNAs and uveal melanoma: Understanding the diverse role of
these small molecular regulators. Int J Mol Sci.
21(5648)2020.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Harbour JW: Eye cancer: Unique insights
into oncogenesis the Cogan lecture. Invest Ophthalmol Vis Sci.
47:1737–1745. 2006.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Pe'er J: Ocular surface squamous
neoplasia: Evidence for topical chemotherapy. Int Ophthalmol Clin.
55:9–21. 2015.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Lee GA and Hirst LW: Ocular surface
squamous neoplasia. Surv Ophthalmol. 39:429–450. 1995.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Vogelstein B and Kinzler KW: Cancer genes
and the pathways they control. Nat Med. 10:789–99. 2004.PubMed/NCBI View
Article : Google Scholar
|
|
9
|
Wang Z: Regulation of cell cycle
progression by growth factor-induced cell signaling. Cells.
10(3327)2021.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Dimaras H, Kimani K, Dimba EA, Gronsdahl
P, White A, Chan HS and Gallie BL: Retinoblastoma. Lancet.
379:1436–1446. 2012.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Kaliki S and Shields CL: Uveal melanoma:
Relatively rare but deadly cancer. Eye (Lond). 31:241–257.
2017.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Brănișteanu DE, Porumb-Andrese E, Stărică
A, Munteanu AC, Toader MP, Zemba M, Porumb V, Cozmin M, Moraru AD,
Nicolescu AC and Brănișteanu DC: Differences and similarities in
epidemiology and risk factors for cutaneous and uveal melanoma.
Medicina (Kaunas). 59(943)2023.PubMed/NCBI View Article : Google Scholar
|
|
13
|
O'shea JG: Environmental factors in the
epidemiology and aetiology of malignant tumours of the eye. Clin
Exp Optom. 79:177–185. 1996.
|
|
14
|
Houtzagers LE, Wierenga AP, Ruys AA,
Luyten GP and Jager MJ: Iris colour and the risk of developing
uveal melanoma. Int J Mol Sci. 21(7172)2020.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Holly EA, Aston DA, Ahm DK and Smith AH:
Intraocular melanoma linked to occupations and chemical exposures.
Epidemiology. 7:55–61. 1996.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Thompson S, Ritz B, Cockburn M and Heck
JE: Prenatal ambient pesticide exposure and childhood
retinoblastoma. Int J Hyg Environ Health.
245(114025)2022.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Behrens T, Lynge E, Cree I, Lutz JM,
Eriksson M, Guénel P, Merletti F, Morales-Suarez-Varela M, Afonso
N, Stengrevics A, et al: Occupational exposure to
endocrine-disrupting chemicals and the risk of uveal melanoma.
Scand J Work Environ Health. 38:476–483. 2012.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Lopes FC, Sleiman MG, Sebastian K, Bogucka
R, Jacobs EA and Adamson AS: UV exposure and the risk of cutaneous
melanoma in skin of color: A systematic review. JAMA Dermatol.
157:213–219. 2021.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Chalada M, Ramlogan-Steel CA, Dhungel BP,
Layton CJ and Steel JC: The impact of ultraviolet radiation on the
aetiology and development of uveal melanoma. Cancers (Basel).
13(1700)2021.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Tarlan B and Kıratlı H: Uveal melanoma:
Current trends in diagnosis and management. Turk J Ophthalmol.
46:123–137. 2016.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Wu M, Yavuzyiğitoğlu S, Brosens E, Ramdas
WD and Kiliç E: Rotterdam Ocular Melanoma Study Group (ROMS).
Worldwide incidence of ocular melanoma and correlation with
pigmentation-related risk factors. Invest Ophthalmol Vis Sci.
64(45)2023.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Botezatu A, Iancu IV, Popa O, Plesa A,
Manda D, Huica I, Vladoiu S, Anton G and Badiu C: Mechanisms of
oncogene activation. New Aspects in Molecular and Cellular
Mechanisms of Human Carcinogenesis. Bulgin D (ed). InTechOpen,
p192, 2016.
|
|
23
|
Kontomanolis EN, Koutras A, Syllaios A,
Schizas D, Kalagasidou S, Pagkalos A, Alatzidou D, Kantari P,
Ntounis T and Fasoulakis Z: Basic principles of molecular biology
of cancer cell-Molecular cancer indicators. J BUON. 26:1723–1734.
2021.PubMed/NCBI
|
|
24
|
Salem MS: Pathogenetics. An introductory
review. Egyptian Journal of Medical Human Genetics. 17:1–23.
2016.
|
|
25
|
Li Y, Giovannini S, Wang T, Fang J, Li P,
Shao C, Wang Y, TOR Centre, Shi Y, Candi E, et al: p63: A crucial
player in epithelial stemness regulation. Oncogene. 42:3371–3384.
2023.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Hong D, Huang HJ, To H, Young LJ, Oro A,
Bookstein R, Lee YH and Lee WH: Structure of the human
retinoblastoma gene. Proc Natl Acad Sci USA. 86:5502–5506.
1989.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Park JJ, Diefenbach RJ, Joshua AM, Kefford
RF, Carlino MS and Rizos H: Oncogenic signaling in uveal melanoma.
Pigment Cell Melanoma Res. 31:661–672. 2018.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Du W and Pogoriler J: Retinoblastoma
family genes. Oncogene. 25:5190–5200. 2006.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Lapadula D and Benovic JL: Targeting
oncogenic gαq/11 in uveal melanoma. Cancers (Basel).
13(6195)2021.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Silva-Rodríguez P, Fernández-Díaz D, Bande
M, Pardo M, Loidi L and Blanco-Teijeiro MJ: GNAQ and GNA11 genes: A
comprehensive review on oncogenesis, prognosis and therapeutic
opportunities in uveal melanoma. Cancers (Basel).
14(3066)2022.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Ma J, Weng L, Bastian BC and Chen X:
Functional characterization of uveal melanoma oncogenes. Oncogene.
40:806–820. 2021.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Barbagallo C, Stella M, Broggi G, Russo A,
Caltabiano R and Ragusa M: Genetics and RNA regulation of uveal
melanoma. Cancers (Basel). 15(775)2023.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Van Raamsdonk CD, Bezrookove V, Green G,
Bauer J, Gaugler L, O'Brien JM, Simpson EM, Barsh GS and Bastian
BC: Frequent somatic mutations of GNAQ in uveal melanoma and blue
naevi. Nature. 457:599–602. 2009.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Gichuhi S, Ohnuma SI, Sagoo MS and Burton
MJ: Pathophysiology of ocular surface squamous neoplasia. Exp Eye
Res. 129:172–182. 2014.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Casciano F, Zauli E, Busin M, Caruso L,
AlMesfer S, Al-Swailem S, Zauli G and Yu AC: State of the art of
pharmacological activators of p53 in ocular malignancies. Cancers
(Basel). 15(3593)2023.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Rossi E, Schinzari G, Maiorano BA,
Pagliara MM, Di Stefani A, Bria E, Peris K, Blasi MA and Tortora G:
Conjunctival melanoma: Genetic and epigenetic insights of a
distinct type of melanoma. Int J Mol Sci. 20(5447)2019.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Chua V, Lapadula D, Randolph C, Benovic
JL, Wedegaertner PB and Aplin AE: Dysregulated GPCR signaling and
therapeutic options in uveal melanoma. Mol Cancer Res. 15:501–506.
2017.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Parinot C and Nandrot EF: A comprehensive
review of mutations in the MERTK proto-oncogene. Adv Exp Med Biol.
854:259–265. 2016.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Croley CR, Pumarol J, Delgadillo BE, Cook
AC, Day F, Kaceli T, Ward CC, Husain I, Husain A, Banerjee S and
Bishayee A: Signaling pathways driving ocular malignancies and
their targeting by bioactive phytochemicals. Pharmacol Ther.
248(108479)2023.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Nie C, Ma H, Gao Y, Li J, Tang Z, Chen Y
and Lu R: RNA sequencing and bioinformatic analysis on
retinoblastoma revealing that cell cycle deregulation is a key
process in retinoblastoma tumorigenesis. Ophthalmologica.
244:51–59. 2021.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Pardo M, Pineiro A, de la Fuente M, García
A, Prabhakar S, Zitzmann N, Dwek RA, Sánchez-Salorio M, Domínguez F
and Capeans C: Abnormal cell cycle regulation in primary human
uveal melanoma cultures. J Cell Biochem. 93:708–720.
2004.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Carella G: Introduction to apoptosis in
ophthalmology. Eur J Ophthalmol. 13 (Suppl 3):S5–S10.
2003.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Tempestini A, Schiavone N, Papucci L,
Witort E, Lapucci A, Cutri M, Donnini M and Capaccioli S: The
mechanisms of apoptosis in biology and medicine: A new focus for
ophthalmology. Eur J Ophthalmol. 13 (Suppl 3):S11–S18.
2003.PubMed/NCBI View Article : Google Scholar
|
|
44
|
Macovei L: Angiogenesis and
antiangiogenesis in intraocular tumors. Oftalmologia. 54:24–26.
2010.PubMed/NCBI(In Romanian).
|
|
45
|
Youssef PN, Sheibani N and Albert DM:
Retinal light toxicity. Eye (Lond). 25:1–14. 2011.PubMed/NCBI View Article : Google Scholar
|
|
46
|
Rosenblatt MI and Azar DT: Anti-angiogenic
therapy: Prospects for treatment of ocular tumors. Semin
Ophthalmol. 21:151–160. 2006.PubMed/NCBI View Article : Google Scholar
|
|
47
|
Gallenga CE, Franco E, Adamo GG, Violanti
SS, Tassinari P, Tognon M and Perri P: Genetic basis and molecular
mechanisms of uveal melanoma metastasis: A focus on prognosis.
Front Oncol. 12(828112)2022.PubMed/NCBI View Article : Google Scholar
|
|
48
|
Sakai A, Tagami M, Kakehashi A,
Katsuyama-Yoshikawa A, Misawa N, Wanibuchi H, Azumi A and Honda S:
Expression, intracellular localization, and mutation of EGFR in
conjunctival squamous cell carcinoma and the association with
prognosis and treatment. PLoS One. 15(e0238120)2020.PubMed/NCBI View Article : Google Scholar
|
|
49
|
Zhong Y, Xu F, Wu J, Schubert J and Li MM:
Application of next generation sequencing in laboratory medicine.
Ann Lab Med. 41:25–43. 2021.PubMed/NCBI View Article : Google Scholar
|
|
50
|
Fallico M, Raciti G, Longo A, Reibaldi M,
Bonfiglio V, Russo A, Caltabiano R, Gattuso G, Falzone L and
Avitabile T: Current molecular and clinical insights into uveal
melanoma (Review). Int J Oncol. 58(10)2021.PubMed/NCBI View Article : Google Scholar
|
|
51
|
Francis JH, Richards AL, Mandelker DL,
Berger MF, Walsh MF, Dunkel IJ, Donoghue MT and Abramson DH:
Molecular changes in retinoblastoma beyond RB1: Findings from
next-generation sequencing. Cancers (Basel). 13(149)2021.PubMed/NCBI View Article : Google Scholar
|
|
52
|
Afshar AR, Pekmezci M, Bloomer MM, Cadenas
NJ, Stevers M, Banerjee A, Roy R, Olshen AB, Van Ziffle J, Onodera
C, et al: Next-generation sequencing of retinoblastoma identifies
pathogenic alterations beyond RB1 inactivation that correlate with
aggressive histopathologic features. Ophthalmology. 127:804–813.
2020.PubMed/NCBI View Article : Google Scholar
|
|
53
|
Li Z, Yu X, Shen J and Jiang Y: MicroRNA
dysregulation in uveal melanoma: A new player enters the game.
Oncotarget. 6:4562–4568. 2015.PubMed/NCBI View Article : Google Scholar
|
|
54
|
Venza M, Dell'Aversana C, Visalli M,
Altucci L, Teti D and Venza I: Identification of microRNA
expression patterns in cutaneous and uveal melanoma cell lines.
Tumori. 100:e4–e7. 2014.PubMed/NCBI View Article : Google Scholar
|
|
55
|
Achberger S, Aldrich W, Tubbs R, Crabb JW,
Singh AD and Triozzi PL: Circulating immune cell and microRNA in
patients with uveal melanoma developing metastatic disease. Mol
Immunol. 58:182–186. 2014.PubMed/NCBI View Article : Google Scholar
|
|
56
|
Iengar P: An analysis of substitution,
deletion and insertion mutations in cancer genes. Nucleic Acids
Res. 40:6401–6413. 2012.PubMed/NCBI View Article : Google Scholar
|
|
57
|
Goh AY, Ramlogan-Steel CA, Jenkins KS,
Steel JC and Layton CJ: Presence and prevalence of UV related
genetic mutations in uveal melanoma: Similarities with cutaneous
melanoma. Neoplasma. 67:958–971. 2020.PubMed/NCBI View Article : Google Scholar
|
|
58
|
Soliman SE, Racher H, Zhang C, MacDonald H
and Gallie BL: Genetics and molecular diagnostics in
retinoblastoma-an update. Asia Pac J Ophthalmol (Phila). 6:197–207.
2017.PubMed/NCBI View Article : Google Scholar
|
|
59
|
Di Girolamo N: Association of human
papilloma virus with pterygia and ocular-surface squamous
neoplasia. Eye (Lond). 26:202–211. 2012.PubMed/NCBI View Article : Google Scholar
|
|
60
|
Alvarez OP, Monroy D, Thura S, Antonietti
M, Fasih-Ahmad S, Sepulveda-Beltran PA, Culbertson S, Dubovy SR,
Galor A and Karp CL: Infectious etiologies of conjunctival tumors.
Expert Rev Ophthalmol. 11:1–6. 2024.
|
|
61
|
Beasley AB, Chen FK, Isaacs TW and Gray
ES: Future perspectives of uveal melanoma blood based biomarkers.
Br J Cancer. 126:1511–1528. 2022.PubMed/NCBI View Article : Google Scholar
|
|
62
|
Grossman D, Okwundu N, Bartlett EK,
Marchetti MA, Othus M, Coit DG, Hartman RI, Leachman SA, Berry EG,
Korde L, et al: Prognostic gene expression profiling in cutaneous
melanoma: Identifying the knowledge gaps and assessing the clinical
benefit. JAMA Dermatol. 156:1004–1011. 2020.PubMed/NCBI View Article : Google Scholar
|
|
63
|
Aaberg TM, Covington KR, Tsai T, Shildkrot
Y, Plasseraud KM, Alsina KM, Oelschlager KM and Monzon FA: Gene
expression profiling in uveal melanoma: Five-year prospective
outcomes and meta-analysis. Ocul Oncol Pathol. 6:360–367.
2020.PubMed/NCBI View Article : Google Scholar
|
|
64
|
Napolitano G, Tagliaferri D, Fusco S,
Cirillo C, De Martino I, Addeo M, Mazzone P, Russo NA, Natale F,
Cardoso MC, et al: A novel member of Prame family, Gm12794c,
counteracts retinoic acid differentiation through the
methyltransferase activity of PRC2. Cell Death Differ. 27:345–362.
2020.PubMed/NCBI View Article : Google Scholar
|
|
65
|
Guan X, Pavani KC, Chunduru J, Broeckx BJ,
Van Soom A and Peelman L: Hsa-miR-665 is a promising biomarker in
cancer prognosis. Cancers (Basel). 15(4915)2023.PubMed/NCBI View Article : Google Scholar
|
|
66
|
Rodríguez MF, Marta BF, Baameiro NL,
Santiago-Varela M, Silva-Rodríguez P, Blanco-Teijeiro MJ, Perez MP
and Ces AP: Blood biomarkers of uveal melanoma: Current
perspectives. Clin Ophthalmol. 20:157–169. 2020.PubMed/NCBI View Article : Google Scholar
|
|
67
|
Bustamante P, Tsering T, Coblentz J,
Mastromonaco C, Abdouh M, Fonseca C, Proença RP, Blanchard N, Dugé
CL, Andujar RA, et al: Circulating tumor DNA tracking through
driver mutations as a liquid biopsy-based biomarker for uveal
melanoma. J Exp Clin Cancer Res. 40(196)2021.PubMed/NCBI View Article : Google Scholar
|
|
68
|
Park JJ, Diefenbach RJ, Byrne N, Long GV,
Scolyer RA, Gray ES, Carlino MS and Rizos H: Circulating tumor DNA
reflects uveal melanoma responses to protein kinase C inhibition.
Cancers (Basel). 13(1740)2021.PubMed/NCBI View Article : Google Scholar
|
|
69
|
Bidard FC, Madic J, Mariani P,
Piperno-Neumann S, Rampanou A, Servois V, Cassoux N, Desjardins L,
Milder M, Vaucher I, et al: Detection rate and prognostic value of
circulating tumor cells and circulating tumor DNA in metastatic
uveal melanoma. Int J Cancer. 134:1207–1213. 2014.PubMed/NCBI View Article : Google Scholar
|
|
70
|
Moore AR, Ceraudo E, Sher JJ, Guan Y,
Shoushtari AN, Chang MT, Zhang JQ, Walczak EG, Kazmi MA, Taylor BS,
et al: Recurrent activating mutations of G-protein-coupled receptor
CYSLTR2 in uveal melanoma. Nat Genet. 48:675–680. 2016.PubMed/NCBI View Article : Google Scholar
|
|
71
|
Eagle RC Jr: Ocular tumors: Triumphs,
challenges and controversies. Saudi J Ophthalmol. 27:129–132.
2013.PubMed/NCBI View Article : Google Scholar
|
|
72
|
Shields CL, Kels JG and Shields JA:
Melanoma of the eye: Revealing hidden secrets, one at a time. Clin
Dermatol. 33:183–196. 2015.PubMed/NCBI View Article : Google Scholar
|
|
73
|
Tsotridou E, Loukovitis E, Tsiropoulos GN,
Zapsalis K, Pentara I, Tzima K, Eminidou V and Anogeianakis G:
Radiation treatment methods in uveal melanoma. Med Hypothesis
Discov Innov Ophthalmol. 10:32–42. 2021.PubMed/NCBI View Article : Google Scholar
|
|
74
|
Finger PT, Rivard MJ, Chaugule SS,
Shanmugam PM, Saakyan S, Krema H, Sagoo MS and Sauerwein WA:
Ophthalmic radiotherapy: Plaques and implants. Surgical ophthalmic
oncology: A collaborative open access reference 2019:147-58.
|
|
75
|
Correia JH, Rodrigues JA, Pimenta S, Dong
T and Yang Z: Photodynamic therapy review: Principles,
photosensitizers, applications, and future directions.
Pharmaceutics. 13(1332)2021.PubMed/NCBI View Article : Google Scholar
|
|
76
|
Bilmin K, Synoradzki KJ, Czarnecka AM,
Spałek MJ, Kujawska T, Solnik M, Merks P, Toro MD, Rejdak R and
Fiedorowicz M: New perspectives for eye-sparing treatment
strategies in primary uveal melanoma. Cancer (Basel).
14(134)2021.PubMed/NCBI View Article : Google Scholar
|
|
77
|
Xie Z, Zhou Z, Yang S, Zhang S and Shao B:
Epigenetic regulation and therapeutic targets in the tumor
microenvironment. Mol Biomed. 4(17)2023.PubMed/NCBI View Article : Google Scholar
|
|
78
|
Morel D, Jeffery D, Aspeslagh S, Almouzni
G and Postel-Vinay S: Combining epigenetic drugs with other
therapies for solid tumours-past lessons and future promise. Nat
Rev Clin Oncol. 17:91–107. 2020.PubMed/NCBI View Article : Google Scholar
|
|
79
|
Basile MS, Mazzon E, Fagone P, Longo A,
Russo A, Fallico M, Bonfiglio V, Nicoletti F, Avitabile T and
Reibaldi M: Immunobiology of uveal melanoma: State of the art and
therapeutic targets. Front Oncol. 9(1145)2019.PubMed/NCBI View Article : Google Scholar
|
|
80
|
Hassel JC, Berking C, Forschner A,
Gebhardt C, Heinzerling L, Meier F, Ochsenreither S, Siveke J,
Hauschild A and Schadendorf D: Practical guidelines for the
management of adverse events of the T cell engager bispecific
tebentafusp. Eur J Cancer. 191(112986)2023.PubMed/NCBI View Article : Google Scholar
|
|
81
|
Mazzarella T, Cambiaghi V, Rizzo N, Pilla
L, Parolini D, Orsenigo E, Colucci A, Modorati G, Doglioni C,
Parmiani G and Maccalli C: Ex vivo enrichment of circulating
anti-tumor T cells from both cutaneous and ocular melanoma
patients: clinical implications for adoptive cell transfer therapy.
Cancer Immunol Immunother. 61:1169–1182. 2012.PubMed/NCBI View Article : Google Scholar
|
|
82
|
Chandran SS, Somerville RP, Yang JC,
Sherry RM, Klebanoff CA, Goff SL, Wunderlich JR, Danforth DN, Zlott
D, Paria BC, et al: Treatment of metastatic uveal melanoma with
adoptive transfer of tumour-infiltrating lymphocytes: A
single-centre, two-stage, single-arm, phase 2 study. Lancet Oncol.
18:792–802. 2017.PubMed/NCBI View Article : Google Scholar
|
|
83
|
Rosenberg SA and Restifo NP: Adoptive cell
transfer as personalized immunotherapy for human cancer. Science.
348:62–68. 2015.PubMed/NCBI View Article : Google Scholar
|
